Alan Penman, Kimberley Crowder
50 Studies Every Ophthalmologist Should Know
Herausgeber: Hochman, Michael E
Alan Penman, Kimberley Crowder
50 Studies Every Ophthalmologist Should Know
Herausgeber: Hochman, Michael E
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.
Andere Kunden interessierten sich auch für
- 50 Studies Every Urologist Should Know58,99 €
- James Y. HungPractical Ophthalmology: A Concise Manual for the Non-ophthalmologist12,99 €
- Sharon FekratThe Duke Manual of Vitreoretinal Surgery147,99 €
- David Hui50 Studies Every Palliative Care Doctor Should Know85,99 €
- Robert T Sataloff50 More Ways to Abuse Your Voice26,99 €
- Moyra SmithJourneys in Medicine and Research on Three Continents Over 50 Years42,99 €
- 50 Landmark Papers Every Spine Surgeon Should Know107,99 €
-
-
-
50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 336
- Erscheinungstermin: 19. Mai 2020
- Englisch
- Abmessung: 231mm x 155mm x 23mm
- Gewicht: 567g
- ISBN-13: 9780190050726
- ISBN-10: 0190050721
- Artikelnr.: 58703444
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Oxford University Press
- Seitenzahl: 336
- Erscheinungstermin: 19. Mai 2020
- Englisch
- Abmessung: 231mm x 155mm x 23mm
- Gewicht: 567g
- ISBN-13: 9780190050726
- ISBN-10: 0190050721
- Artikelnr.: 58703444
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Dr. Alan Penman is a physician with specialty training in ophthalmology, public health, epidemiology, and biostatistics. He graduated MBChB from Aberdeen University Medical School, Scotland in 1979, and received an MSc in Clinical Tropical Medicine from London University, England in 1981, an MPH from the University of Alabama (Birmingham) in 1998, and a PhD in Biostatistics from the University of Mississippi in 2008. He completed his training in ophthalmology at Aberdeen Royal Infirmary in 1989, followed by a retinal fellowship at the MRC Sickle Cell Clinic in Kingston, Jamaica from 1990-1992. As a Professor in the Departments of Preventive Medicine and Ophthalmology at the University of Mississippi Medical Center (UMMC), Dr. Penman consults regularly with investigators conducting clinical studies and population research. In addition, he directs and teaches courses in epidemiology, biostatistics, public health and disease prevention for medical students and graduate medical faculty. Dr. Kimberly Crowder is Professor and Chair of the Department of Ophthalmology at the University of Mississippi Medical Center. She completed her ophthalmology residency at UMMC in 2003, joining the department's faculty immediately afterward, and serving as the program director for the Medical Center's ophthalmology residents from 2007-2015. She was promoted to department chair in 2015. Dr. Crowder's motivation stems from her desire to improve ophthalmology education for residents and students. Since 2003, she has been an active attending physician in ophthalmology and filled multiple roles including course director for medical student electives in ophthalmology, course director of Family and Emergency Medicine resident rotations in ophthalmology, and director for the resident eye clinic. She has twice been named "Ophthalmology Faculty of the year" by the UMMC Ophthalmology residents. Dr. Crowder is board certified by the American Board of Ophthalmology and practices comprehensive ophthalmology. She's a member of a number of professional societies, among them the American Academy of Ophthalmology, for which she is currently serving on a Residency education task force. She is also a member of the Association of American Medical Colleges' Council of Faculty and Academic Societies, as well as the Mississippi Academy of Eye Physicians and Surgeons, and the Association for Research in Vision and Ophthalmology.
* 1. Effectiveness of Histocompatibility Matching in High-Risk Corneal
Transplantation
* 2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis
* 3. Topical Corticosteroids for Bacterial Keratitis
* 4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer
* 5. Prevalence of Age-Related Lens Opacities in a Population
* 6. Risk Factors for Cataract
* 7. High-Dose Supplementation with Vitamins C and E and Beta Carotene
for Age-Related Cataract and Vision Loss
* 8. Routine Preoperative Medical Testing Before Cataract Surgery.
* 9. Prophylaxis of Postoperative Endophthalmitis Following Cataract
Surgery
* 10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma
* 11. Is argon laser trabeculoplasty equivalent to topical medication
as an initial treatment for primary open-angle glaucoma?
* 12. Intraocular Pressure Reduction in the Treatment of Normal-Tension
Glaucoma
* 13. The Relationship Between Control of Intraocular Pressure after
Surgical Intervention for Glaucoma and Visual Field Deterioration
* 14. Reduction of intraocular pressure and glaucoma progression
* 15. Topical ocular hypotensive medication to delay or prevent the
onset of primary open-angle glaucoma
* 16. Intraocular Pressure Control and Long-Term Visual Field Loss in
Open-Angle Glaucoma
* 17. Latanoprost for Open-Angle Glaucoma
* 18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior
Ocular Surgery and Uncontrolled Glaucoma
* 19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and
the Ahmed Versus Baerveldt Study
* 20. Risk Factors for Branch and Central Retinal Vein Occlusion
* 21. Argon Laser Photocoagulation for Macular Edema in Branch Vein
Occlusion
* 22. Intraocular Injections of Ranibizumab in Patients With Macular
Edema Following Branch Retinal Vein Occlusion
* 23. Grid Pattern Photocoagulation for Macular Edema in Central Vein
Occlusion
* 24. Steroids in the Treatment of Central Retinal Vein Occlusion
* 25. Cryotherapy for Retinopathy of Prematurity
* 26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of
Prematurity
* 27. Early Treatment of Prethreshold Retinopathy of Prematurity
* 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
* 29. Photocoagulation for Diabetic Macular Edema
* 30. Early Photocoagulation for Diabetic Retinopathy
* 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients
with Complications of Proliferative Diabetic Retinopathy
* 32. Intensive Diabetes Management to Reduce the Risk of Retinopathy
Developing or Progressing
* 33. Progression of retinopathy and vision loss related to tight blood
pressure control in type 2 diabetes mellitus
* 34. Immediate Vitrectomy and Intravenous Antibiotics for the
Treatment of Postoperative Bacterial Endophthalmitis
* 35. Prevalence of Age-Related Maculopathy
* 36. Does high-dose supplementation with vitamins C and E, beta
carotene, and zinc slow the progression of age-related macular
degeneration and vision loss?
* 37. Argon laser photocoagulation for extrafoveal neovascular
maculopathy
* 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in
Age-related Macular Degeneration with Verteporfin
* 39. Pegaptanib for Neovascular Age-Related Macular Degeneration
* 40. Ranibizumab for Neovascular Age-Related Macular Degeneration
* 41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular
Degeneration
* 42. Effect of Pre-Enucleation Radiation on Mortality in Large
Choroidal Melanomas
* 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide
* 44. Botulinum A Toxin Injection into Extraocular Muscles as an
Alternative to Strabismus Surgery
* 45. Botulinum A Toxin Injection as a Treatment for Blepharospasm
* 46. A Clinical Activity Score That Discriminates Between Inflammatory
and Non-Inflammatory Graves' Ophthalmopathy
* 47. Corticosteroids in the Treatment of Acute Optic Neuritis
* 48. Atropine or Patching for Treatment of Moderate Amblyopia in
Children
* 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia
During Infancy
* 50. Effect of Acetazolamide on Visual Function in Patients With
Idiopathic Intracranial Hypertension and Mild Visual Loss
Transplantation
* 2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis
* 3. Topical Corticosteroids for Bacterial Keratitis
* 4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer
* 5. Prevalence of Age-Related Lens Opacities in a Population
* 6. Risk Factors for Cataract
* 7. High-Dose Supplementation with Vitamins C and E and Beta Carotene
for Age-Related Cataract and Vision Loss
* 8. Routine Preoperative Medical Testing Before Cataract Surgery.
* 9. Prophylaxis of Postoperative Endophthalmitis Following Cataract
Surgery
* 10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma
* 11. Is argon laser trabeculoplasty equivalent to topical medication
as an initial treatment for primary open-angle glaucoma?
* 12. Intraocular Pressure Reduction in the Treatment of Normal-Tension
Glaucoma
* 13. The Relationship Between Control of Intraocular Pressure after
Surgical Intervention for Glaucoma and Visual Field Deterioration
* 14. Reduction of intraocular pressure and glaucoma progression
* 15. Topical ocular hypotensive medication to delay or prevent the
onset of primary open-angle glaucoma
* 16. Intraocular Pressure Control and Long-Term Visual Field Loss in
Open-Angle Glaucoma
* 17. Latanoprost for Open-Angle Glaucoma
* 18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior
Ocular Surgery and Uncontrolled Glaucoma
* 19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and
the Ahmed Versus Baerveldt Study
* 20. Risk Factors for Branch and Central Retinal Vein Occlusion
* 21. Argon Laser Photocoagulation for Macular Edema in Branch Vein
Occlusion
* 22. Intraocular Injections of Ranibizumab in Patients With Macular
Edema Following Branch Retinal Vein Occlusion
* 23. Grid Pattern Photocoagulation for Macular Edema in Central Vein
Occlusion
* 24. Steroids in the Treatment of Central Retinal Vein Occlusion
* 25. Cryotherapy for Retinopathy of Prematurity
* 26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of
Prematurity
* 27. Early Treatment of Prethreshold Retinopathy of Prematurity
* 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
* 29. Photocoagulation for Diabetic Macular Edema
* 30. Early Photocoagulation for Diabetic Retinopathy
* 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients
with Complications of Proliferative Diabetic Retinopathy
* 32. Intensive Diabetes Management to Reduce the Risk of Retinopathy
Developing or Progressing
* 33. Progression of retinopathy and vision loss related to tight blood
pressure control in type 2 diabetes mellitus
* 34. Immediate Vitrectomy and Intravenous Antibiotics for the
Treatment of Postoperative Bacterial Endophthalmitis
* 35. Prevalence of Age-Related Maculopathy
* 36. Does high-dose supplementation with vitamins C and E, beta
carotene, and zinc slow the progression of age-related macular
degeneration and vision loss?
* 37. Argon laser photocoagulation for extrafoveal neovascular
maculopathy
* 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in
Age-related Macular Degeneration with Verteporfin
* 39. Pegaptanib for Neovascular Age-Related Macular Degeneration
* 40. Ranibizumab for Neovascular Age-Related Macular Degeneration
* 41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular
Degeneration
* 42. Effect of Pre-Enucleation Radiation on Mortality in Large
Choroidal Melanomas
* 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide
* 44. Botulinum A Toxin Injection into Extraocular Muscles as an
Alternative to Strabismus Surgery
* 45. Botulinum A Toxin Injection as a Treatment for Blepharospasm
* 46. A Clinical Activity Score That Discriminates Between Inflammatory
and Non-Inflammatory Graves' Ophthalmopathy
* 47. Corticosteroids in the Treatment of Acute Optic Neuritis
* 48. Atropine or Patching for Treatment of Moderate Amblyopia in
Children
* 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia
During Infancy
* 50. Effect of Acetazolamide on Visual Function in Patients With
Idiopathic Intracranial Hypertension and Mild Visual Loss
* 1. Effectiveness of Histocompatibility Matching in High-Risk Corneal
Transplantation
* 2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis
* 3. Topical Corticosteroids for Bacterial Keratitis
* 4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer
* 5. Prevalence of Age-Related Lens Opacities in a Population
* 6. Risk Factors for Cataract
* 7. High-Dose Supplementation with Vitamins C and E and Beta Carotene
for Age-Related Cataract and Vision Loss
* 8. Routine Preoperative Medical Testing Before Cataract Surgery.
* 9. Prophylaxis of Postoperative Endophthalmitis Following Cataract
Surgery
* 10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma
* 11. Is argon laser trabeculoplasty equivalent to topical medication
as an initial treatment for primary open-angle glaucoma?
* 12. Intraocular Pressure Reduction in the Treatment of Normal-Tension
Glaucoma
* 13. The Relationship Between Control of Intraocular Pressure after
Surgical Intervention for Glaucoma and Visual Field Deterioration
* 14. Reduction of intraocular pressure and glaucoma progression
* 15. Topical ocular hypotensive medication to delay or prevent the
onset of primary open-angle glaucoma
* 16. Intraocular Pressure Control and Long-Term Visual Field Loss in
Open-Angle Glaucoma
* 17. Latanoprost for Open-Angle Glaucoma
* 18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior
Ocular Surgery and Uncontrolled Glaucoma
* 19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and
the Ahmed Versus Baerveldt Study
* 20. Risk Factors for Branch and Central Retinal Vein Occlusion
* 21. Argon Laser Photocoagulation for Macular Edema in Branch Vein
Occlusion
* 22. Intraocular Injections of Ranibizumab in Patients With Macular
Edema Following Branch Retinal Vein Occlusion
* 23. Grid Pattern Photocoagulation for Macular Edema in Central Vein
Occlusion
* 24. Steroids in the Treatment of Central Retinal Vein Occlusion
* 25. Cryotherapy for Retinopathy of Prematurity
* 26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of
Prematurity
* 27. Early Treatment of Prethreshold Retinopathy of Prematurity
* 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
* 29. Photocoagulation for Diabetic Macular Edema
* 30. Early Photocoagulation for Diabetic Retinopathy
* 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients
with Complications of Proliferative Diabetic Retinopathy
* 32. Intensive Diabetes Management to Reduce the Risk of Retinopathy
Developing or Progressing
* 33. Progression of retinopathy and vision loss related to tight blood
pressure control in type 2 diabetes mellitus
* 34. Immediate Vitrectomy and Intravenous Antibiotics for the
Treatment of Postoperative Bacterial Endophthalmitis
* 35. Prevalence of Age-Related Maculopathy
* 36. Does high-dose supplementation with vitamins C and E, beta
carotene, and zinc slow the progression of age-related macular
degeneration and vision loss?
* 37. Argon laser photocoagulation for extrafoveal neovascular
maculopathy
* 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in
Age-related Macular Degeneration with Verteporfin
* 39. Pegaptanib for Neovascular Age-Related Macular Degeneration
* 40. Ranibizumab for Neovascular Age-Related Macular Degeneration
* 41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular
Degeneration
* 42. Effect of Pre-Enucleation Radiation on Mortality in Large
Choroidal Melanomas
* 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide
* 44. Botulinum A Toxin Injection into Extraocular Muscles as an
Alternative to Strabismus Surgery
* 45. Botulinum A Toxin Injection as a Treatment for Blepharospasm
* 46. A Clinical Activity Score That Discriminates Between Inflammatory
and Non-Inflammatory Graves' Ophthalmopathy
* 47. Corticosteroids in the Treatment of Acute Optic Neuritis
* 48. Atropine or Patching for Treatment of Moderate Amblyopia in
Children
* 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia
During Infancy
* 50. Effect of Acetazolamide on Visual Function in Patients With
Idiopathic Intracranial Hypertension and Mild Visual Loss
Transplantation
* 2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis
* 3. Topical Corticosteroids for Bacterial Keratitis
* 4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer
* 5. Prevalence of Age-Related Lens Opacities in a Population
* 6. Risk Factors for Cataract
* 7. High-Dose Supplementation with Vitamins C and E and Beta Carotene
for Age-Related Cataract and Vision Loss
* 8. Routine Preoperative Medical Testing Before Cataract Surgery.
* 9. Prophylaxis of Postoperative Endophthalmitis Following Cataract
Surgery
* 10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma
* 11. Is argon laser trabeculoplasty equivalent to topical medication
as an initial treatment for primary open-angle glaucoma?
* 12. Intraocular Pressure Reduction in the Treatment of Normal-Tension
Glaucoma
* 13. The Relationship Between Control of Intraocular Pressure after
Surgical Intervention for Glaucoma and Visual Field Deterioration
* 14. Reduction of intraocular pressure and glaucoma progression
* 15. Topical ocular hypotensive medication to delay or prevent the
onset of primary open-angle glaucoma
* 16. Intraocular Pressure Control and Long-Term Visual Field Loss in
Open-Angle Glaucoma
* 17. Latanoprost for Open-Angle Glaucoma
* 18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior
Ocular Surgery and Uncontrolled Glaucoma
* 19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and
the Ahmed Versus Baerveldt Study
* 20. Risk Factors for Branch and Central Retinal Vein Occlusion
* 21. Argon Laser Photocoagulation for Macular Edema in Branch Vein
Occlusion
* 22. Intraocular Injections of Ranibizumab in Patients With Macular
Edema Following Branch Retinal Vein Occlusion
* 23. Grid Pattern Photocoagulation for Macular Edema in Central Vein
Occlusion
* 24. Steroids in the Treatment of Central Retinal Vein Occlusion
* 25. Cryotherapy for Retinopathy of Prematurity
* 26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of
Prematurity
* 27. Early Treatment of Prethreshold Retinopathy of Prematurity
* 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
* 29. Photocoagulation for Diabetic Macular Edema
* 30. Early Photocoagulation for Diabetic Retinopathy
* 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients
with Complications of Proliferative Diabetic Retinopathy
* 32. Intensive Diabetes Management to Reduce the Risk of Retinopathy
Developing or Progressing
* 33. Progression of retinopathy and vision loss related to tight blood
pressure control in type 2 diabetes mellitus
* 34. Immediate Vitrectomy and Intravenous Antibiotics for the
Treatment of Postoperative Bacterial Endophthalmitis
* 35. Prevalence of Age-Related Maculopathy
* 36. Does high-dose supplementation with vitamins C and E, beta
carotene, and zinc slow the progression of age-related macular
degeneration and vision loss?
* 37. Argon laser photocoagulation for extrafoveal neovascular
maculopathy
* 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in
Age-related Macular Degeneration with Verteporfin
* 39. Pegaptanib for Neovascular Age-Related Macular Degeneration
* 40. Ranibizumab for Neovascular Age-Related Macular Degeneration
* 41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular
Degeneration
* 42. Effect of Pre-Enucleation Radiation on Mortality in Large
Choroidal Melanomas
* 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide
* 44. Botulinum A Toxin Injection into Extraocular Muscles as an
Alternative to Strabismus Surgery
* 45. Botulinum A Toxin Injection as a Treatment for Blepharospasm
* 46. A Clinical Activity Score That Discriminates Between Inflammatory
and Non-Inflammatory Graves' Ophthalmopathy
* 47. Corticosteroids in the Treatment of Acute Optic Neuritis
* 48. Atropine or Patching for Treatment of Moderate Amblyopia in
Children
* 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia
During Infancy
* 50. Effect of Acetazolamide on Visual Function in Patients With
Idiopathic Intracranial Hypertension and Mild Visual Loss